{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:31:23Z","timestamp":1761964283087},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T00:00:00Z","timestamp":1293062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respirology"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background and objective:\u2003<\/jats:bold> The impact of pandemic influenza A (H1N1)v infection is still unknown but it is associated with a high case\u2010fatality rate.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> This was a prospective, observational, multicentre study conducted in 144 Spanish intensive care units. Demographic and clinical data were reviewed for all cases of pandemic influenza A (H1N1)v infection reported from 23 June 2009 through 11 February 2010 and confirmed by reverse transcriptase PCR assay.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> Out of 872 cases reported by statewide surveillance, data for the first 131 deceased patients were analysed. Thirty\u2010seven patients (28.2%) died within the first 14 days. The median age of these patients was 46 years (interquartile range 35\u201358) and 60.3% were male. Twenty\u2010eight patients (21.4%) did not present with any comorbidities on admission. Forty\u2010six per cent of patients were reported to be obese and 22 (16.8%) had COPD. The vast majority of the patients (72.5%) had viral pneumonia; 95.4% of these had bilateral patchy alveolar opacities (predominantly basal), affecting three or four quadrants. One hundred and fifteen patients (87.8%) developed multi\u2010organ dysfunction syndrome. Ninety\u2010seven patients (74%) required vasopressor drugs, 37 (27.2%) received renal replacement therapy, and 47 (35.1%) received intravenous corticosteroids on admission to the intensive care unit. Only 68 patients (51.9%) received empirical antiviral treatment.<\/jats:p><jats:p><jats:bold>Conclusions:\u2003<\/jats:bold> One\u2010third of patients with pandemic influenza A (H1N1)v infection died within the first two weeks and these were young patients, with rapidly progressive viral pneumonia as the primary cause of admission. Obese patients were at high risk but one in four patients did not present with any risk factors on admission. Only half the patients received empirical antiviral therapy and this was administered late.<\/jats:p>","DOI":"10.1111\/j.1440-1843.2010.01874.x","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T14:57:22Z","timestamp":1287068242000},"page":"78-85","source":"Crossref","is-referenced-by-count":24,"title":["Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain"],"prefix":"10.1111","volume":"16","author":[{"given":"Ignacio","family":"MARTIN\u2010LOECHES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"RODRIGUEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"BONASTRE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"ZARAGOZA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"SIERRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"MARQUES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"JULI\u00c1\u2010NARVAEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emili","family":"DIAZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"RELLO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The H1N1 SEMICYUC Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,23]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"ECDC.Pandemic (H1N1) 2009. 16 February 2010 Update. [Accessed 20 February 2010.] Available from URL:http:\/\/ecdc.europa.eu\/en\/healthtopics\/Documents\/100217_Influenza_A(H1N1)_Weekly_Executive_Update.pdf."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc8044"},{"key":"e_1_2_6_4_2","unstructured":"CDC Protocol of Realtime RT\u2010PCR for Influenza A (H1N1). World Health Organization Geneva April 2009. [Accessed 27 February 2010.] Available from URL:http:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/realtimeptpcr\/en\/index.html."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61304-0"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/511159"},{"key":"e_1_2_6_7_2","first-page":"593","volume-title":"Community\u2010acquired Pneumonia","author":"Cate TR","year":"2001"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc2872"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198510000-00009"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709751"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904252"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1496"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908481"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904023"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc8208"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/650581"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181cde600"},{"key":"e_1_2_6_18_2","unstructured":"ContiG LarrssonA NavaSet\u2003al.On the role of non\u2010invasive ventilation (NIV) to treat patients during the H1N1 influenza pandemic.2010. [Accessed 19 March 2010.] Available from URL:http:\/\/dev.ersnet.org\/uploads\/Document\/63\/WEB_CHEMIN_5410_1258624143.pdf."},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc8883"},{"key":"e_1_2_6_20_2","first-page":"1071","article-title":"Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)\u2014United States, May\u2013August 2009","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc8183"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.01.004"},{"key":"e_1_2_6_23_2","unstructured":"World Health Organization.WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. 20 August 2009. [Accessed 19 March 2010.] Available from URL:http:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/h1n1_use_antivirals_20090820\/en\/index.html."},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/600384"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906695"},{"key":"e_1_2_6_26_2","unstructured":"HienTT BryantJE TruongNTet\u2003al.ProMed\u2010mail. 11 October 2009. [Accessed 19 March 2010.] Available from URL:http:\/\/www.promedmail.org\/pls\/otn\/f?p2400:1001:3634633565218674::NO::F2400_P1001_BACK_PAGE F2400_P1001_PUB_MAIL_ID:1000 79587."}],"container-title":["Respirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1843.2010.01874.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1843.2010.01874.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T01:39:51Z","timestamp":1697247591000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1843.2010.01874.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,23]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1440-1843.2010.01874.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1843.2010.01874.x","archive":["Portico"],"relation":{},"ISSN":["1323-7799","1440-1843"],"issn-type":[{"type":"print","value":"1323-7799"},{"type":"electronic","value":"1440-1843"}],"subject":[],"published":{"date-parts":[[2010,12,23]]}}}